RA Capital Management
Overview
RA Capital Management is a multi-stage investment manager that focuses on evidence-based investing in public and private healthcare and life science companies developing drugs, medical devices, diagnostics, services, and research tools.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Circle Pharma | Sep 2026 | Series E | Co-investor |
| Planted Solar | Sep 2026 | Early Funding | Lead |
| Solstice Oncology | Sep 2026 | Series A | Lead |
| Superluminal Medicines | Sep 2026 | Series B | Co-investor |
| Typewriter Therapeutics | Sep 2026 | Series A | Lead |
Key People
Brigid O'Brien
Managing Partner, Planetary Health
Kyle Teamey
Managing Partner, Planetary Health
Peter Kolchinsky
Managing Partner
Emmanuel Bassey
Senior Partner
Genevieve Cross
Senior Partner
Suvendu Pal
Senior Partner
Adam Kaye
Senior Managing Director And Partner, Structured Capital
Joshua Resnick
Partner And Senior Managing Director
Laura Tadvalkar
Managing Director
Nandita Shangari
Managing Director
Fanny Cavalie
Venture Partner
Habib Dable
Venture Partner (Part-Time)
Mario Barro
Venture Partner And Head Of Infectious Diseases At RA Capital
Robert Nicol
Venture Partner
CFP® Gillian DeSilva
Advisor, Family Office And Partner Services
Derek DiRocco
Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
